{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:29:08Z","timestamp":1773296948469,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.medcli.2011.02.022","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T13:41:55Z","timestamp":1327758115000},"page":"57-59","source":"Crossref","is-referenced-by-count":10,"title":["Tolerabilidad de la inhalaci\u00f3n de dos soluciones salinas hipert\u00f3nicas en pacientes con fibrosis qu\u00edstica"],"prefix":"10.1016","volume":"138","author":[{"given":"Luis","family":"M\u00e1iz Carro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelaida","family":"Lamas Ferreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ruiz de Valbuena Maiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Wagner Struwing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Gabilondo \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrecia","family":"Su\u00e1rez Cortina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2011.02.022_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2011.02.022_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2011.02.022_bib0015","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.medcli.2011.02.022_bib0020","doi-asserted-by":"crossref","unstructured":"Buonpensiero P, De Gregorio F, Sepe A, Di Pasqua A, Ferri P, Siano M, et al. Hyaluronic acid improves \u201cpleasantness\u201d and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis. Adv Ther. 2010;27:870-878.","DOI":"10.1007\/s12325-010-0076-8"},{"key":"10.1016\/j.medcli.2011.02.022_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mcp.0000245714.89632.b2","article-title":"Inhaled hypertonic saline as a therapy for cystic fibrosis","volume":"12","author":"Elkins","year":"2006","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.medcli.2011.02.022_bib0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(01)06412-1","article-title":"Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial","volume":"358","author":"Suri","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2011.02.022_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<282::AID-PPUL3>3.0.CO;2-P","article-title":"Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: a pilot study","volume":"21","author":"Rodwell","year":"1996","journal-title":"Pediatr Pulmonol."},{"key":"10.1016\/j.medcli.2011.02.022_bib0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/156720108783954815","article-title":"Advanced nebulizer designs employing vibrating mesh\/aperture plate technologies for aerosol generation","volume":"5","author":"Waldrep","year":"2008","journal-title":"Current Drug Deliv."},{"key":"10.1016\/j.medcli.2011.02.022_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/jamp.2007.0652","article-title":"Aerosolized antibiotics for non-cystic fibrosis bronchiectasis","volume":"21","author":"Rubin","year":"2008","journal-title":"J Aerosol Med Pulm Drug Delivery."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531100296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531100296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T20:40:07Z","timestamp":1561236007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577531100296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S002577531100296X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2011.02.022","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}